316 related articles for article (PubMed ID: 7696203)
41. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
[TBL] [Abstract][Full Text] [Related]
42. Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes.
Hussain S; Salojin KV; Delovitch TL
Diabetes; 2004 Aug; 53(8):2003-11. PubMed ID: 15277379
[TBL] [Abstract][Full Text] [Related]
43. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
Pankewycz O; Strom TB; Rubin-Kelley VE
Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
[TBL] [Abstract][Full Text] [Related]
44. Local activation of dendritic cells leads to insulitis and development of insulin-dependent diabetes in transgenic mice expressing CD154 on the pancreatic beta-cells.
Haase C; Skak K; Michelsen BK; Markholst H
Diabetes; 2004 Oct; 53(10):2588-95. PubMed ID: 15448088
[TBL] [Abstract][Full Text] [Related]
45. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
46. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells.
Allison J; McClive P; Oxbrow L; Baxter A; Morahan G; Miller JF
Eur J Immunol; 1994 Oct; 24(10):2535-41. PubMed ID: 7925581
[TBL] [Abstract][Full Text] [Related]
47. I-E+ nonobese diabetic mice develop insulitis and diabetes.
Podolin PL; Pressey A; DeLarato NH; Fischer PA; Peterson LB; Wicker LS
J Exp Med; 1993 Sep; 178(3):793-803. PubMed ID: 8350054
[TBL] [Abstract][Full Text] [Related]
48. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
49. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.
Planas R; Alba A; Carrillo J; Puertas MC; Ampudia R; Pastor X; Okamoto H; Takasawa S; Gurr W; Pujol-Borrell R; Verdaguer J; Vives-Pi M
Diabetologia; 2006 Oct; 49(10):2379-87. PubMed ID: 16900387
[TBL] [Abstract][Full Text] [Related]
50. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event.
Anderson JT; Cornelius JG; Jarpe AJ; Winter WE; Peck AB
Autoimmunity; 1993; 15(2):113-22. PubMed ID: 8105989
[TBL] [Abstract][Full Text] [Related]
51. Age-dependent sensitivity to streptozotocin of pancreatic islets isolated from female NOD mice.
Reddy S; Sandler S
Autoimmunity; 1995; 22(2):121-6. PubMed ID: 8722582
[TBL] [Abstract][Full Text] [Related]
52. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
53. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
54. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
55. A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model.
Birk OS; Douek DC; Elias D; Takacs K; Dewchand H; Gur SL; Walker MD; van der Zee R; Cohen IR; Altmann DM
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1032-7. PubMed ID: 8577709
[TBL] [Abstract][Full Text] [Related]
56. Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis.
Pilström B; Björk L; Böhme J
Cytokine; 1995 Nov; 7(8):806-14. PubMed ID: 8664448
[TBL] [Abstract][Full Text] [Related]
57. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.
Moriyama H; Abiru N; Paronen J; Sikora K; Liu E; Miao D; Devendra D; Beilke J; Gianani R; Gill RG; Eisenbarth GS
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10376-81. PubMed ID: 12925730
[TBL] [Abstract][Full Text] [Related]
58. Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.
Coulaud J; Durant S; Homo-Delarche F
Rev Diabet Stud; 2010; 7(1):36-46. PubMed ID: 20703437
[TBL] [Abstract][Full Text] [Related]
59. Immunogenetic analysis of beta-cell autoimmunity in NOD mice. Relationship of insulitis to T-lymphocyte-receptor beta nod and A beta nod genes.
Winter WE; Shimpo K; Obata M; Yamada K; Luchetta R
Diabetes; 1990 Aug; 39(8):975-82. PubMed ID: 1973674
[TBL] [Abstract][Full Text] [Related]
60. Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background.
Makino S; Harada M; Kishimoto Y; Hayashi Y
Jikken Dobutsu; 1986 Oct; 35(4):495-8. PubMed ID: 3542537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
